BRCA1 Breast Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart

Biomarkers: BRCA1 mutation

She had a complete pathologic response to breast chemotherapy and later reported no evidence of breast cancer.

MD AndersonRead more →

Stage III HER2-Positive Breast Cancer: Christine's Survivor Story

Patient Info: Christine Elliott, Female, Under 40 | Stage III

Biomarkers: Estrogen receptor-positive; HER2 and progesterone receptor status not reported

As of May 2023, Christine was about 3 years from diagnosis and in survivorship after chemotherapy, lumpectomy, and radiation. She reported lasting physical and emotional effects but did not state a formal NED status.

YouTube — The Patient StoryRead more →

Stage IV Breast Cancer: Valerie's Patient Story

Patient Info: Valerie Frank, Female, 40s | Stage IV

Metastatic Site: bone, lung, liver

Living with Stage IV breast cancer after recurrence in the bones, lungs and liver in January 2022, with oncology and palliative care support.

Dana-FarberRead more →

Stage IV HR-Positive Breast Cancer: Abigail's Patient Story

Patient Info: Abigail Myers, female, Under 40 | Stage IV

Biomarkers: ER-positive, PR-positive, HER2-positive

Metastatic Site: bones, brain

Abigail continued living with Stage IV metastatic breast cancer after about 8 years of multiple treatment lines, including therapy for bone and brain metastases.

Dana-FarberRead more →

Chemotherapy complication: methotrexate absorbed into the bloodstream after spinal injection

Patient Info: Anonymized, Female | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative; Oncotype DX Recurrence Score 20

Metastatic Site: leptomeninges / central nervous system; brain

Five months after leptomeningeal carcinomatosis was recognised, she developed a new 2 cm brain lesion and neurological decline. Her family chose supportive care, and she died 10 days after transfer to inpatient hospice.

PubMed CentralRead more →

Stage IIB Breast Cancer Treatment Followed by BRCA1 Testing

Patient Info: Anonymized, Female | Stage II

Biomarkers: BRCA1 pathogenic variant

She completed 10 years of endocrine therapy without evidence of breast-cancer recurrence.

PubMed CentralRead more →

Triple-Negative Bilateral Breast Cancer Treated With Surgery, Radiation, and Oral Chemotherapy

Patient Info: Anonymized, Female | Stage I

Biomarkers: Triple-negative breast cancer; germline BRCA1 pathogenic variant confirmed later

She completed radiotherapy and 2 years of tegafur-uracil without evidence of breast-cancer recurrence.

PubMed CentralRead more →

Rare breast blood-vessel cancer (angiosarcoma) in a teenage girl

Patient Info: Anonymized, Female

Biomarkers: Testing for Li-Fraumeni syndrome and POT1 mutation was inconclusive; no inherited cancer predisposition was established

She remained in remission 3 years after diagnosis and continued annual MRI surveillance of the reconstructed and opposite breasts.

PubMed CentralRead more →

BRCA2 Breast Cancer: Sue's Survivor Story

Patient Info: Sue Friedman, Female, Under 40

Biomarkers: BRCA2 mutation

As of February 2023, Sue Friedman was a long-term breast cancer survivor and founder of FORCE after a BRCA2-associated breast cancer and recurrence; the video is educational and does not state current active disease, NED, or metastatic status for Sue.

The Patient StoryRead more →

Stage II Breast Cancer: Renée's Patient Story

Patient Info: Renée, Female, Under 40 | Stage II

Biomarkers: Not genetically inherited; breast cancer linked by her team to prior doxorubicin exposure and total-body radiation

As of February 2023, Renée described stable health, working treatments, good bloodwork, and ongoing long-term hormone/anti-cancer therapy; she did not consider herself cancer-free and preferred survivor/thriver language.

The Patient StoryRead more →

Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy E., Female, Under 40

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had been told she was all-clear/cancer-free after chemotherapy, had undergone double mastectomy with staged reconstruction planning, and was continuing close oncology reviews every 3-4 months.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Patient Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had gone through fertility preservation, chemotherapy, and double mastectomy for Stage II grade 3 triple-negative breast cancer with BRCA1 mutation; no NED or recurrence status was stated.

The Patient StoryRead more →

Stage II HER2-Positive Invasive Ductal Carcinoma: Lanie's Patient Story

Patient Info: Lanie Jones, Female, Under 40 | Stage II

Biomarkers: HER2-positive; Li-Fraumeni syndrome / TP53 mutation; BRCA-negative

As of January 2023, Lanie was living with Li-Fraumeni syndrome after 5 cancer diagnoses and was on lifelong maintenance chemotherapy while advocating for genetic testing and specialized surveillance.

The Patient StoryRead more →

Stage II Breast Cancer: Jamie's Patient Story

Patient Info: Jamie, Female, 40s | Stage II

Jamie was newly diagnosed with Stage II breast cancer in 2023 and had not yet started treatment; her plan included mastectomy, chemotherapy, radiation therapy, and targeted therapy.

Our Cancer StoriesRead more →

Breast Cancer: Teri's Survivor Story

Patient Info: Teri

Her cancer is in remission, and she continues hormone therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Char's Patient Story

Patient Info: Char, Female, 40s | Stage II

As of 2023, Char was focused on surviving Stage II breast cancer after lumpectomy, lymphadenectomy, chemotherapy, and radiotherapy, while rebuilding diet, exercise, work, family life, and mental health.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Joanna's Survivor Story

Patient Info: Joanna, Female, Under 40 | Stage III

By late 2023, Joanna had completed treatment for Stage III breast cancer, was no longer taking medication, and described herself as living free of cancer.

Our Cancer StoriesRead more →

Inflammatory Breast Cancer and Dermatomyositis Improve Together With Treatment

Patient Info: Anonymized, female, 70+

Biomarkers: ER-positive, PR-positive, HER2-positive

When her dermatomyositis symptoms later worsened, CT, breast ultrasound and bone scans found no breast-cancer recurrence.

PubMed CentralRead more →

Stage I Breast Cancer: Karen's Patient Story

Patient Info: Karen, Female, 50s | Stage I

Karen was diagnosed with Stage I breast cancer in October 2023 and was receiving ongoing chemotherapy as part of a recommended plan that also included lumpectomy and radiation therapy.

Our Cancer StoriesRead more →

Stage I Triple-Negative Breast Cancer: Tracy's Patient Story

Patient Info: Tracy | Stage I

Biomarkers: Triple-negative

Some time after treatment, Tracy remained worried that her triple-negative breast cancer might not go away.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Daniela's Survivor Story

Patient Info: Daniela, Female, 50s | Stage II

Daniela was declared cancer-free in March 2024 after mastectomy, lymphadenectomy, chemotherapy, and radiation therapy for Stage II breast cancer.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Pearline's Patient Story

Patient Info: Pearline | Stage III

Pearline remained on chemotherapy while a proposed restaging from Stage 2 to Stage 3C was still under discussion.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Angelina's Patient Story

Patient Info: Angelina, Female, 50s | Stage II

As of 2023, Angelina was undergoing Stage II breast cancer treatment with DIEP mastectomy, chemotherapy, radiation therapy, and hormone therapy, and was focused on recuperation and future goals.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Diana's Patient Story

Patient Info: Diana, Female, 40s | Stage III

As of 2023, Diana was receiving treatment for Stage III breast cancer after quadrantectomy, chemotherapy, radiation therapy, hormone therapy, unilateral oncological mammoplasty, and lymph-node removal.

Our Cancer StoriesRead more →